These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9264745)

  • 1. [Visceral leishmaniasis in Niger: six new parasitologically confirmed cases].
    Djidingar D; Chippaux JP; Gragnic G; Tchani O; Meynard D; Julvez J
    Bull Soc Pathol Exot; 1997; 90(1):27-9. PubMed ID: 9264745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Visceral kala-azar of Spanish origin. Apropos of a case].
    De Caluwé JP; Lievens P; Trolin C; Heimann R; Delcourt A; Taelman H
    Acta Clin Belg; 1988; 43(5):349-55. PubMed ID: 3061269
    [No Abstract]   [Full Text] [Related]  

  • 3. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
    Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
    Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kala azar with disseminated dermal leishmaniasis.
    Kumar PV; Sadeghi E; Torabi S
    Am J Trop Med Hyg; 1989 Feb; 40(2):150-3. PubMed ID: 2919725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Isolated laringeal leishmaniasis and bone marrow culture (reply)].
    Benítez MD; Miranda C; Navarro JM; Morillas F; Martín J; de La Rosa M
    Enferm Infecc Microbiol Clin; 2002 Mar; 20(3):133-4. PubMed ID: 11904090
    [No Abstract]   [Full Text] [Related]  

  • 6. [The first case of visceral leishmaniasis in a patient with HIV infection in Russia].
    Ermak TN; Kravchenko AV; Gruzdev BM; Filippov PG
    Ter Arkh; 1997; 69(11):48-50. PubMed ID: 9483748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.
    Singh RP; Picado A; Alam S; Hasker E; Singh SP; Ostyn B; Chappuis F; Sundar S; Boelaert M
    Trop Med Int Health; 2012 Nov; 17(11):1345-8. PubMed ID: 22882665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal visceral leishmaniasis, with massive bone-marrow infection, in an immunosuppressed but HIV-negative Spanish patient, after the initiation of treatment with meglumine antimoniate.
    Garcia-Cordoba F; Ortuño FJ; Segovia M; Gonzalez Diaz G
    Ann Trop Med Parasitol; 2005 Mar; 99(2):125-30. PubMed ID: 15814031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric visceral leishmaniasis in Western Sicily, Italy: a retrospective analysis of 111 cases.
    Cascio A; Colomba C; Antinori S; Orobello M; Paterson D; Titone L
    Eur J Clin Microbiol Infect Dis; 2002 Apr; 21(4):277-82. PubMed ID: 12072938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Kala-azar. Apropos of a case report in a Belgian woman].
    Coutellier P; Delgrange B
    Acta Clin Belg; 1989; 44(5):362-3. PubMed ID: 2609847
    [No Abstract]   [Full Text] [Related]  

  • 11. PCR for diagnosis and assessment of cure in kala-azar patients in Bangladesh.
    Salam MA; Mondal D; Kabir M; Ekram AR; Haque R
    Acta Trop; 2010 Jan; 113(1):52-5. PubMed ID: 19769932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Childhood visceral leishmaniasis in the Alpes-Maritimes from 1985 to 1992].
    Marty P; Léger I; Albertini M; Gari-Toussaint M; Tommasi C; Manassero J; Le Fichoux Y; Mariani R
    Bull Soc Pathol Exot; 1994; 87(2):105-9. PubMed ID: 8061526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of kala-azar in India.
    Thakur CP
    Natl Med J India; 1992; 5(5):203-5. PubMed ID: 1338871
    [No Abstract]   [Full Text] [Related]  

  • 14. [Visceral leishmaniasis in immunocompetent adult with severe sepsis].
    Ezzouine H; Charra B; Benslama A; Motaouakkil S
    Ann Fr Anesth Reanim; 2010 Mar; 29(3):255-6. PubMed ID: 20227234
    [No Abstract]   [Full Text] [Related]  

  • 15. Para-kala-azar dermal leishmaniasis in a patient in Brazil: a case report.
    Lindoso JAL; Moreira CHV; Celeste BJ; Oyafuso LKM; Folegatti PM; Zijlstra EE
    Rev Soc Bras Med Trop; 2018; 51(1):105-107. PubMed ID: 29513829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study.
    Laguna F; Videla S; Jiménez-Mejías ME; Sirera G; Torre-Cisneros J; Ribera E; Prados D; Clotet B; Sust M; López-Vélez R; Alvar J;
    J Antimicrob Chemother; 2003 Sep; 52(3):464-8. PubMed ID: 12888588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visceral leishmaniasis in District Dir, NWFP.
    Rahim F; Rehman F; Ahmad S; Zada B
    J Pak Med Assoc; 1998 Jun; 48(6):161-2. PubMed ID: 9813985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinico-epidemiological study of kala-azar in the south of Madrid].
    de la Serna FJ; Salto E; Valdés D; Vos Saus R
    Rev Sanid Hig Publica (Madr); 1987; 61(7-8):783-98. PubMed ID: 3438697
    [No Abstract]   [Full Text] [Related]  

  • 19. [Acute pancreatitis during treatment with meglumine antimoniate (Glucantime)].
    Barthet M; Brunet P; Bernard JC; Dussol B; Rodor F; Jouglard J; Berland Y; Sahel J
    Gastroenterol Clin Biol; 1994; 18(1):90-2. PubMed ID: 8187998
    [No Abstract]   [Full Text] [Related]  

  • 20. Visceral leishmaniasis treatment, Italy.
    Gradoni L; Gramiccia M; Scalone A
    Emerg Infect Dis; 2003 Dec; 9(12):1617-20. PubMed ID: 14720406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.